However, given our results implicating both E2F4 and E2F6 complexes in A3B repression, we reasoned that effects from these and other potentially confounding variables may be overcome by asking whether the APOBEC mutation signature is enriched in breast tumors with functional overexpression of an E2F-repressed 20 gene set. This evidence concerns the gene E2F6 and breast neoplasm.